Informing collaborative relationships between community pharmacists and health care professionals in primary care practices.

Background: Collaborative relationships between community pharmacists and health care professionals in primary care practices can assist with the provision of medication and disease management services in community pharmacy settings.

Objectives: The objective was to describe the attitudes of providers working in primary care practices with on-site pharmacist collaborators to understand how to facilitate similar collaborations with pharmacists in community pharmacy settings.

Methods: This qualitative study was conducted among physicians, nurse practitioners, and nurses of 3 primary care practice sites in the Commonwealth of Pennsylvania.

Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.

Aim: To evaluate factors influencing cardiologists' perspectives about pharmacogenomic (PGx) testing in clinical practice.

Patients & Methods: Semistructured interviews with practicing cardiologists were qualitatively analyzed to identify common themes.

Results: Five themes were identified among 16 cardiologists from four specialties (n = 5 general cardiology, n = 3 electrophysiology, n = 2 adult congenital and n = 6 heart failure/transplant): cardiologists' knowledge and needs, perceived clinical validity and utility of PGx testing, dissemination and management of PGx results, patient-related considerations and incidental findings.

Metabolic monitoring in children 5 years of age and younger prescribed second-generation antipsychotic medications.

Introduction: The objective of this article was to identify the rates of patients ≤5 years of age who received recommended monitoring before and after second-generation antipsychotic (SGA) initiation and had an SGA metabolic adverse effect (MAE).

Methods: This was a retrospective cohort analysis conducted at Kaiser Permanente Colorado, an integrated health care delivery system, between January 1, 2002, and June 30, 2011. Commercially insured patients ≤5 years of age newly initiated on an SGA were included.

Patient Specific Factors Influencing Adherence to INR Monitoring.

Objective: The specific reasons underlying nonadherence to monitoring the international normalized ratio (INR) from the patient's perspective have not been formally studied. Understanding why patients do or do not adhere has the potential to reveal useful targets for improving adherence to INR monitoring or alternative treatment strategies. The objective of this study was to gain further insight into INR monitoring nonadherence from the patient's perspective.